Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 20 Source: CRO
- €4.1 billion turnover
-
-€121.6 million
profit - 11,500 employees
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
- 6 more years available »
Ranking
By Turnover
(€4.1 billion)- 30th in Top Companies
- 8th in Health
- 5th in Pharma
By Employees
(11,500)- 19th in Top Companies
- 4th in Health
- 3rd in Pharma
-
- 11,500
- €4.1 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- 6:03pm Batteries could save consumer €34m a year, study finds
- 4:35pm Expectations build for more than three US rate rises this year
- 11:23am US private equity giant Apollo eyes checking out of 11 Irish Travelodges
- Jan 15 Pharma boss barred from industry for life over price gouging
- Jan 15 Mortgage repayments cheaper than rent in all but two areas